21^st World Congress on Radiology & Cancer Research Aug 27-28, 2018 Toronto, Ontario, Canada

From 1995 to 2000, after 20 years of research using all of my collective information, I did by my own funds in millions /helped only by my family and money I earned from my different small business/ of US $, I was able to realize my goal of creating a device to heal humanity. Using quantum mechanics in physic, electromagnetic science and Chinese Acupuncture Science in Medicine making comparison with west US science in Medicine, I created my life's vision and destiny. I canceled the magnetic aspect of Nikola Tesla AC industrial electricity to create a proprietary invention and discovery of bio-electricity. This bio-electricity has the ability to release bio electron photons which can cleanse plaque in entire vascular system including tiny capillaries’, as well as dead cells (oxidized protein) and other sick cells located in the fiber tissue of any of human physical organ.

Laser device, bio electrons and bio electron photons, quantum mechanics,Cancer

Born in Ivory Coast in 1979, he graduated from the Bouaké School of Medicine (Ivory Coast) in 2006.In 2013, he became a specialist in medical imaging (University Houphouet Boigny Abidjan) then graduated in emergency imaging at the University Paris Diderot (France) Currently a research professor at Houphouet Boigny Abidjan University, he is involved in research on neurological and musculoskeletal pathologies in tropical environments

Nuclear Medicine, Radiology & Radiation Therapy

Professor Yoshiaki Omura received Oncology Residency Training and a Doctor of Science Degree through research on Pharmaco-Electro Physiology of Single Cells in Vivo and in Vitro from Columbia University. He published over 250 articles and 7 books. He is currently Editor-in-Chief of Acupuncture & Electro-Therapeutics Research, International Journal of Integrated Medicine, and Executive Editor of Integrative Oncology. Using his new diagnostic method, which received U.S. patent, he can non-invasively and rapidly measure many neurotransmitters, chemicals, asbestos, viruses, and bacteria. He developed a non-invasive, quick diagnostic method of malignancies, as well as a method of evaluating the effects of any treatment.

Cancer Research

Dr. Gary J Whitman is a tenured professor of radiology and radiation oncology at The University of Texas MD Anderson Cancer Center, where he serves as the medical director of the mobile mammography program. Dr. Whitman joined the MDACC faculty in 1996 after serving on the faculty at Harvard Medical School and Massachusetts General Hospital. Dr. Whitman is the current chair of the MDACC Faculty Senate and he serves on the institutional executive committee and the Physicians Referral Service executive committee. Dr. Whitman is a fellow of the American College of Radiology, the Society of Breast Imaging, the Society of Ultrasound in Radiology, and the American Institute of Ultrasound in Medicine. Dr. Whitman is the president of the Association of University Radiologists, and he is the program chair for the American Roentgen Ray Society. Dr. Whitman is the vice chair of the RSNA News, published by the Radiological Society of North America

Digital Mammography (Screening, diagnosis, tomosynthesis, and intervention) Breast Ultrasound Breast MRI

Dr. Vermorken served on the medical staff of oncology, at the University Hospital Vrije Universiteit in Amsterdam, The Netherlands, and is Emeritus Professor of Oncology at the University of Antwerp and past head of the Department of Medical Oncology at the Antwerp University Hospital in Edegem, Belgium, where he still works as a consultant. Dr. Vermorken was principal investigator of the OncoVAX 8701 Phase IIIa clinical trial. Dr. Vermorken’s main field of interest is in gynecological oncology, and head and neck oncology. In addition, he coordinated large clinical trials in breast and colon cancer, including the OncoVAX’s Phase III trial (8701). His main research areas concern early clinical and pharmacological studies with new drugs, studies on the interaction of chemotherapy and radiation therapy, HPV in various malignancies and immunological approaches. Dr. Vermorken is a member of the European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group (GCG) and the EORTC Head and Neck Cancer Group (HNCG). He chaired the EORTC-GCG from 1983 to 1989 and the EORTC-HNCG from 2006 to 2009. He is still an active member with both groups.

Oncology,Head and Neck Cancer,

Dr. Wassil Nowicky — Dipl. Ing., Dr. techn., DDDr. h. c., Director of “Nowicky Pharma” and President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). Has finished his study at the Radiotechnical Faculty of the Technical University of Lviv (Ukraine) with the end of 1955 with graduation to “Diplomingeniueur” in 1960 which title was nostrificated in Austria in 1975. Dr. Wassil Nowicky became the very first scientist in the development of the anticancer protonic therapy and is the inventor of the preparation against cancer with a selective effect on basis of celandine alkaloids “NSC-631570”. He used the factor that cancer cells are more negative charged than normal cells and invented the Celandine alkaloid with a positive charge thanks to which it accumulates in cancer cells very fast. Author of over 300 scientific articles dedicated to cancer research. Dr. Wassil Nowicky is a real member of the New York Academy of Sciences, member of the European Union for applied immunology and of the American Association for scientific progress, honorary doctor of the Janka Kupala University in Hrodno, doctor “honoris causa” of the Open international university on complex medicine in Colombo, honorary member of the Austrian Society of a name of Albert Schweizer. He has received the award for merits of National guild of pharmacists of America. the award of Austrian Society of sanitary, hygiene and public health services and others.

Anticancer protonic therapy